医薬品原薬（API）の世界市場：2017〜2021年

2017年から2021年の世界における医薬品原薬（API）市場のCAGR（複合年間成長率）は、6.61%となることが予測されています。

当レポートでは、世界における医薬品原薬（API）市場の動向や将来予測、成長因子と課題、主要ベンダーの分析などの情報を提供しています。

第1章　エグゼクティブサマリー

第2章　調査範囲

• 市場概要

第3章　市場調査手法

• 調査手法
• 経済指標

第4章　イントロダクション

第5章　市場情勢

• 世界の医薬品原薬（API）市場
• ファイブフォース分析

第6章　生産プロセス別の市場区分

• 世界の医薬品原薬（API）市場：生産プロセス別
• 合成医薬品原薬
• バイオ医薬品原薬

第7章　製品タイプ別の市場区分

• 世界の医薬品原薬（API）市場：製品タイプ別

第8章　ベンダータイプ別の市場区分

• 世界の医薬品原薬（API）市場：ベンダータイプ別
• キャプティブ（自社製）API市場
• マーチャント型API市場

第9章　地理区分

• 世界の医薬品原薬（API）市場：地理区分別
• 南北アメリカ
• アジア太平洋地域
• 欧州・中東・アフリカ地域
• その他の地域

第10章　市場成長因子

第11章　成長因子の影響

第12章　市場の課題

第13章　成長因子と課題の影響

第14章　市場動向

第15章　ベンダー情勢

• 競合シナリオ
• Aurobindo Pharma
• Cipla
• Dr. Reddy's Laboratories
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries
• その他の有力ベンダー

第16章　付録

• 略語リスト

第17章　Technavioについて

図表

• Exhibit 01: Global APIs market
• Exhibit 02: Market segmentation by production process
• Exhibit 03: Market segmentation by type
• Exhibit 04: Market segmentation by vendors
• Exhibit 05: Market segmentation by geography
• Exhibit 06: Global APIs market 2016-2021 ($ billions)
• Exhibit 07: Forecast of global APIs market 2016-2021
• Exhibit 08: Five forces analysis
• Exhibit 09: Global APIs market by production process 2016 and 2021
• Exhibit 10: Global synthetic APIs market 2016-2021
• Exhibit 11: Forecast for synthetic APIs market 2016-2021
• Exhibit 12: Global biotech APIs market 2016-2021 ($ billions)
• Exhibit 13: Forecast of biotech APIs market 2016-2021
• Exhibit 14: Global biotech APIs market by product type 2016
• Exhibit 15: Global APIs market by type 2016 and 2021
• Exhibit 16: Global conventional APIs market 2016-2021 ($ billions)
• Exhibit 17: Forecast of conventional APIs market 2016-2021
• Exhibit 18: Global HPAPIs market 2016-2021 ($ billions)
• Exhibit 19: Forecast of HPAPIs market 2016-2021
• Exhibit 20: Global HPAPIs market by production process 2016
• Exhibit 21: Global HPAPIs market by type 2016
• Exhibit 22: Global APIs market by vendor type 2016 and 2021
• Exhibit 23: Global captive APIs market 2016-2021 ($ billions)
• Exhibit 24: Forecast of captive APIs market 2016-2021
• Exhibit 25: Global merchant APIs market 2016-2021 ($ billions)
• Exhibit 26: Forecast of merchant APIs market 2016-2021
• Exhibit 27: Global merchant APIs market by type 2016
• Exhibit 28: Global APIs market by geography 2016 and 2021
• Exhibit 29: APIs market in Americas 2016-2021 ($ billions)
• Exhibit 30: Forecast of APIs market in Americas 2016-2021
• Exhibit 31: Key leading countries in APIs market in Americas 2016
• Exhibit 32: APIs market in APAC 2016-2021 ($ billions)
• Exhibit 33: Forecast of APIs market in APAC 2016-2021
• Exhibit 34: Key leading countries in APIs market in APAC 2016
• Exhibit 35: APIs market in EMEA 2016-2021 ($ billions)
• Exhibit 36: Forecast of APIs market in EMEA 2016-2021
• Exhibit 37: Key leading countries in APIs market in EMEA 2016
• Exhibit 38: Global APIs market by therapeutic areas 2016
• Exhibit 39: Impact of drivers
• Exhibit 40: R&D spending % change 2013-2022
• Exhibit 41: Impact of drivers and challenges
• Exhibit 42: Key vendors of global APIs market
• Exhibit 43: Aurobindo Pharma: Business segmentation
• Exhibit 44: Cipla: Business segmentation
• Exhibit 45: Dr. Reddy's Laboratories: Business segmentation by revenue 2015
• Exhibit 46: Sun Pharmaceutical Industries Limited: Business segmentation by revenue 2015
• Exhibit 47: Teva Pharmaceutical Industries: Business segmentation

About Active Pharmaceutical Ingredients

A drug is generally composed of APIs and excipients. Active Pharmaceutical Ingredients are chemical compounds or a combination of compounds that are used primarily to have the desired effect on biological systems. Excipients are inactive ingredients in a drug that are used to disperse APIs. APIs may be synthesized either through chemical or biotechnological methods.

Technavio's analysts forecast the global active pharmaceutical ingredients market to grow at a CAGR of 6.61% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global active pharmaceutical ingredients market for 2017-2021. To calculate the market size, the report considers the sales of APIs in key applications areas of the pharmaceutical industry. The report considers the revenue generated from the sales of cardiovascular drugs, diabetes drugs, central nervous system (CNS) drugs, oncology drugs, and others.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

Technavio's report, Global Active Pharmaceutical Ingredients Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

• Aurobindo Pharma
• Cipla
• Dr. Reddy's Laboratories
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries

Other Prominent Vendors

• Abbott Laboratories
• Albemarle
• Amgen
• BASF
• Biocon
• Boehringer Ingelheim
• Bristol-Myers Squibb
• CIRON Drugs & Pharmaceuticals
• Dishman Pharmaceuticals and Chemicals
• Emcure Pharmaceuticals
• Ipca Laboratories
• Johnson Matthey
• Guilin Pharmaceutical
• Johnson & Johnson
• Lonza Group
• Merck
• Novartis
• Pfizer
• Roche

Market driver

• Strong focus on HPAPI
• For a full, detailed list, view our report

Market challenge

• Government regulations
• For a full, detailed list, view our report

Market trend

• Growing influence of key markets
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

• Market overview

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights
• Overview

PART 05: Market landscape

• Global APIs market
• Five forces analysis

PART 06: Market segmentation by production process

• Global APIs market by production process
• Global synthetic APIs market
• Global biotech APIs market

PART 07: Market segmentation by type

• Global APIs market by type

PART 08: Market segmentation by vendor type

• Global APIs market by vendor type
• Global captive APIs market
• Global merchant APIs market

PART 09: Geographic segmentation

• Global APIs market by geography
• APIs market in Americas
• APIs market in APAC
• APIs market in EMEA
• Global APIs market by therapeutic areas

PART 10: Market drivers

• Increasing incidence of age-related diseases globally
• Strong focus on HPAPI
• Measures against counterfeit drugs

PART 11: Impact of drivers

PART 12: Market challenges

• Government regulations
• Fierce competition among API manufacturers
• Less R&D spending
• Availability of counterfeit products

PART 13: Impact of drivers and challenges

PART 14: Market trends

• Growing influence of key markets
• Emergence of Africa
• Increasing outsourcing activities

PART 15: Vendor landscape

• Competitive scenario
• Aurobindo Pharma
• Cipla
• Dr. Reddy's Laboratories
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries
• Other prominent vendors

PART 16: Appendix

• List of abbreviations

PART 17: Explore Technavio